ATORX — Alligator Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK105.65m
- SEK105.06m
- SEK0.51m
Brief: Alligator Intends To Carry Out Rights Issue Of Units Of About SEK 199 Mln
Brief: Alligator Bioscience Q4 Oper Loss Widens To SEK 52.6 Mln
Brief: Alligator Bioscience Announces Positive Interim Results From Phase 2 Trial
Brief: Alligator Bioscience And Orion Corporation Initiate Second Program Of Immuno-Oncology Research Collaboration And License Agreement
Brief: Alligator Bioscience: Data Confirm Mitazalimab's Manageable Safety Profile
Brief: Alligator Bioscience Q3 Oper Loss Widens To SEK 51.4 Mln
Brief: Alligator Bioscience Announces Positive Safety Data
Brief: Alligator Bioscience, Aptevo Therapeutics Announce FDA Issues "May Proceed" Notification
Brief: Alligator Bioscience Q2 Loss Widens To SEK 45.7 Million
Brief: Alligator Bioscience Q1 Operating Loss Widens To SEK 43.0 Mln
Brief: Alligator Bioscience Q4 Net Sales At SEK 5.2 Mln
Brief: Alligator Starts Research Deal With University Of Pennsylvania
Brief: Alligator Bioscience Announces Optimize-1 Trial Update; Cohort Fully Dosed With No Adverse Effects Reported
Brief: Alligator Bioscience Announces Trial Update
Brief: Alligator Announces Final Outcome Of Rights Issue
Brief: Alligator Announces Preliminary Outcome Of Rights Issue
Brief: Alligator Operating Loss Widens To SEK 37.7 Mln
Brief: Alligator Bioscience Carries Out A 100% Secured Rights Issue Of About SEK 257 Million
Brief: Alligator Is Exploring Financing Alternatives